Increasing financial pressures and alternative payment models are challenging providers to develop more cost-effective strategies for joint replacement procedures. In this environment, an evidence-based approach to device selection is essential for reducing unnecessary care variation, lowering costs and improving patient care.
This presentation highlights the importance of appropriate implant selection and utilization of ancillary devices in managing costs and provide strategies for successfully optimizing inpatient and post-acute care in a value-based environment.
Key questions we address include:
- How will value-based care and alternative payment models impact orthopedics?
- When does clinical evidence support the use of premium implants and ancillary products?
- How does clinical evidence help achieve cost and quality targets in the inpatient and post-acute care settings?